Msn Laboratories Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CLEVIDIPINE BUTYRATE, with a corresponding US DMF Number 34634.
Remarkably, this DMF maintains an Active status since its submission on February 28, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 30, 2025, and payment made on March 18, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II